140 related articles for article (PubMed ID: 35646176)
1. The role of epithelial membrane antigen (EMA) overexpression in the prognosis of prostatic adenocarcinoma.
Ghalib R; Falah A
J Med Life; 2022 Apr; 15(4):504-508. PubMed ID: 35646176
[TBL] [Abstract][Full Text] [Related]
2. Keratins versus epithelial membrane antigen in tumor diagnosis: an immunohistochemical comparison of five monoclonal antibodies.
Thomas P; Battifora H
Hum Pathol; 1987 Jul; 18(7):728-34. PubMed ID: 2439436
[TBL] [Abstract][Full Text] [Related]
3. Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies.
Pinkus GS; Kurtin PJ
Hum Pathol; 1985 Sep; 16(9):929-40. PubMed ID: 2993153
[TBL] [Abstract][Full Text] [Related]
4. A comparison of epithelial membrane antigen overexpression in benign and malignant endometrium.
Coronado PJ; Fasero M; Vidart JA; Puerta J; Magrina J; Furio-Bacete V; Escudero M
Gynecol Oncol; 2001 Sep; 82(3):483-8. PubMed ID: 11520144
[TBL] [Abstract][Full Text] [Related]
5. High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.
Rabien A; Fritzsche F; Jung M; Diamandis EP; Loening SA; Dietel M; Jung K; Stephan C; Kristiansen G
Tumour Biol; 2008; 29(1):1-8. PubMed ID: 18497543
[TBL] [Abstract][Full Text] [Related]
6. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases.
Hull D; Ma J; Singh H; Hossain D; Qian J; Bostwick DG
BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995
[TBL] [Abstract][Full Text] [Related]
7. Immunoexpression of epithelial membrane antigen in canine meningioma: Novel results for perspective considerations.
Mandara MT; Foiani G; Silvestri S; Chiaradia E
Vet Comp Oncol; 2021 Mar; 19(1):115-122. PubMed ID: 32875656
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
Xiao GQ; Burstein DE; Miller LK; Unger PD
Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
11. [An immunohistochemical study of the distribution of epithelial membrane antigen (EMA) in uterine carcinoma].
Fukuda K; Fujimoto I; Masubuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):739-45. PubMed ID: 3598270
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
Coogan CL; Bostwick DG; Bloom KJ; Gould VE
Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of new monoclonal antibodies--E29, 115D8 --to an epithelial membrane antigen (EMA) in ovarian tumors].
Fujimoto I; Fukuda K; Hang SP; Hasumi K; Masubuchi K; Osamura Y; Watanabe K
Gan No Rinsho; 1987 Nov; 33(14):1798-804. PubMed ID: 2826841
[TBL] [Abstract][Full Text] [Related]
14. Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.
Heyderman E; Larkin SE; O'Donnell PJ; Haines AM; Warren PJ; Northeast A; Grant AG
J Clin Pathol; 1990 Jun; 43(6):448-52. PubMed ID: 1696288
[TBL] [Abstract][Full Text] [Related]
15. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer.
Sadasivan R; Morgan R; Jennings S; Austenfeld M; Van Veldhuizen P; Stephens R; Noble M
J Urol; 1993 Jul; 150(1):126-31. PubMed ID: 7685420
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].
Allina DO; Kekeeva TV; Moskvina LV; Shikeeva AA; Andreeva YY; Zavalishina LE; Frank GA
Arkh Patol; 2015; 77(5):36-42. PubMed ID: 26978019
[TBL] [Abstract][Full Text] [Related]
18. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
19. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Marchal C; Redondo M; Padilla M; Caballero J; Rodrigo I; García J; Quian J; Boswick DG
Histol Histopathol; 2004 Jul; 19(3):715-8. PubMed ID: 15168332
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of epithelial membrane antigen (EMA) to discriminate between perineural invasion and perineural indentation in prostatic carcinoma.
Tsuzuki T; Ujihira N; Ando T
Histopathology; 2005 Aug; 47(2):159-65. PubMed ID: 16045776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
